Integrated metabolomic, systems-pharmacology and in vivo characterization of the nephroprotective effects of Baliospermum solanifolium leaf extract in cisplatin-induced acute kidney injury and mercuric chloride nephrotoxicity

Background Acute kidney injury (AKI) is a clinically significant syndrome marked by a rapid decline in renal function, with high morbidity and limited effective therapies. The multifactorial pathogenesis of AKI involves oxidative stress, inflammation, and regulated cell death, contributing to a high risk of chronic kidney disease and mortality. Natural products, with their multitarget potential, offer promising avenues for nephroprotection, but require rigorous chemical and mechanistic validation. Aim This study evaluated the nephroprotective potential of a chemically profiled ethanolic leaf extract of Baliospermum solanifolium by integrating untargeted metabolomic profiling and systems pharmacology with in vivo assessment in cisplatin-induced acute kidney injury and repeated mercuric chloride-induced nephrotoxicity. Methods Fresh B. solanifolium leaves were extracted with ethanol, followed by untargeted UHPLC–Orbitrap MS/MS profiling, chemical classification, and in silico pharmacokinetic and drug-likeness prioritization. Network pharmacology and computational target prediction were integrated with AKI-associated gene sets to identify overlapping targets and pathways. Hub targets were prioritized for molecular docking and 200 ns molecular dynamics simulations. The extract was evaluated in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity using serum renal-function indices and qualitative histopathology. Results UHPLC–Orbitrap MS/MS annotation identified 525 putative metabolites, 66 of which were prioritized for pharmacological analysis. Network and module analyses revealed key overlaps with inflammatory, survival, hypoxic, and cell-death pathways. HSP90AA1, STAT3, ESR1, and MAPK1 were prioritized for structure-based studies, and molecular docking plus MD simulations supported target-specific binding hypotheses for selected phytocompounds. In vivo , the extract produced numerical improvements across the administered dose levels in body weight and serum renal-function indices across both experimental paradigms, together with qualitative histomorphological improvement, particularly at higher doses. Conclusion The ethanolic leaf extract of B. solanifolium showed biochemical evidence consistent with preventive renal protection in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity. The study supports a chemically anchored, hypothesis-generating multitarget framework integrating high-resolution metabolomics, systems pharmacology and in vivo pharmacological evaluation. These findings provide a basis for future mechanistic and translational validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.1967955
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated metabolomic, systems-pharmacology and in vivo characterization of the nephroprotective effects of Baliospermum solanifolium leaf extract in cisplatin-induced acute kidney injury and mercuric chloride nephrotoxicity

Vandana Sadananda, K. S. Rajesh, Savin S Amin, Chigateri M. Vinay et al.
6 links
Frontiers in Pharmacology
Chemotherapy-induced organ toxicity mitigation
article

Integrated metabolomic, systems-pharmacology and in vivo characterization of the nephroprotective effects of Baliospermum solanifolium leaf extract in cisplatin-induced acute kidney injury and mercuric chloride nephrotoxicity

Vandana Sadananda, K. S. Rajesh, Savin S Amin, Chigateri M. Vinay, Thottethodi Subrahmanya Keshava Prasad, Bhat Gowrish S., Fathima Fareeha, Akhila Hosur Shrungeswara
article en

Abstract

Background Acute kidney injury (AKI) is a clinically significant syndrome marked by a rapid decline in renal function, with high morbidity and limited effective therapies. The multifactorial pathogenesis of AKI involves oxidative stress, inflammation, and regulated cell death, contributing to a high risk of chronic kidney disease and mortality. Natural products, with their multitarget potential, offer promising avenues for nephroprotection, but require rigorous chemical and mechanistic validation. Aim This study evaluated the nephroprotective potential of a chemically profiled ethanolic leaf extract of Baliospermum solanifolium by integrating untargeted metabolomic profiling and systems pharmacology with in vivo assessment in cisplatin-induced acute kidney injury and repeated mercuric chloride-induced nephrotoxicity. Methods Fresh B. solanifolium leaves were extracted with ethanol, followed by untargeted UHPLC–Orbitrap MS/MS profiling, chemical classification, and in silico pharmacokinetic and drug-likeness prioritization. Network pharmacology and computational target prediction were integrated with AKI-associated gene sets to identify overlapping targets and pathways. Hub targets were prioritized for molecular docking and 200 ns molecular dynamics simulations. The extract was evaluated in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity using serum renal-function indices and qualitative histopathology. Results UHPLC–Orbitrap MS/MS annotation identified 525 putative metabolites, 66 of which were prioritized for pharmacological analysis. Network and module analyses revealed key overlaps with inflammatory, survival, hypoxic, and cell-death pathways. HSP90AA1, STAT3, ESR1, and MAPK1 were prioritized for structure-based studies, and molecular docking plus MD simulations supported target-specific binding hypotheses for selected phytocompounds. In vivo , the extract produced numerical improvements across the administered dose levels in body weight and serum renal-function indices across both experimental paradigms, together with qualitative histomorphological improvement, particularly at higher doses. Conclusion The ethanolic leaf extract of B. solanifolium showed biochemical evidence consistent with preventive renal protection in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity. The study supports a chemically anchored, hypothesis-generating multitarget framework integrating high-resolution metabolomics, systems pharmacology and in vivo pharmacological evaluation. These findings provide a basis for future mechanistic and translational validation.

Frontiers in PharmacologyVol. 17
Nitte University (IN), M S Ramaiah University of Applied Sciences (IN), M. S. Ramaiah Dental College and Hospital (IN), M S Ramaiah Memorial Hospital (IN), Ramaiah Institute of Technology (IN), K S Hegde Medical Academy (IN)
Good health and well-being
Chemotherapy-induced organ toxicity mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon